Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer.
Cancer. 2010 Oct 15;116(20):4825-32. doi: 10.1002/cncr.25396.
Cancer. 2010.
PMID: 20597134
Free PMC article.
Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines.
Loewen GM, Tracy E, Blanchard F, Tan D, Yu J, Raza S, Matsui S, Baumann H.
Loewen GM, et al.
BMC Cancer. 2005 Nov 4;5:145. doi: 10.1186/1471-2407-5-145.
BMC Cancer. 2005.
PMID: 16271139
Free PMC article.
This study compared the cytokine responses of normal epithelial cells to that of premalignant cells. METHODS: Short-term primary cultures of epithelial cells were established from bronchial brushings. ...
This study compared the cytokine responses of normal epithelial cells to that of premalignant cells. METHODS: Short-term primary cult …
Item in Clipboard
Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.
Tan D, et al. Among authors: loewen g.
Hum Pathol. 2003 Jun;34(6):597-604. doi: 10.1016/s0046-8177(03)00180-1.
Hum Pathol. 2003.
PMID: 12827614
To assess the prevalence of TTF-1 expression, and to evaluate its potential role in disease prognosis, 140 stage I-IIIA NSCLCs with long-term follow-up were studied under uniform conditions using high-density tissue microarray (TMA) combined with immunohistochemistry. ...
To assess the prevalence of TTF-1 expression, and to evaluate its potential role in disease prognosis, 140 stage I-IIIA NSCLCs with long- …
Item in Clipboard
Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.
Raghavan D, Perez R, Creaven P, Takita H, Loewen G, Vaickus L.
Raghavan D, et al. Among authors: loewen g.
Semin Oncol. 1994 Jun;21(3 Suppl 6):1-8.
Semin Oncol. 1994.
PMID: 8052868
Review.
New cytotoxic agents, such as ifosfamide, etoposide, and carboplatin, have contributed to a reduced toxicity profile and an increase in complete response rates to combination regimens of 40% to 50%, but they have not contributed to any major increase in long-term survival. …
New cytotoxic agents, such as ifosfamide, etoposide, and carboplatin, have contributed to a reduced toxicity profile and an increase in comp …
Item in Clipboard
Cite
Cite